Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of SGLT2 Inhibitor on Renal Function and Urinary [TIMP-2] x [IGFBP7] in Patients Hospitalized for Acute Heart Failure
TCTR20221003002Phase 4Unknown
- Sponsor
- N/A
- Start
- Aug 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial in Acute Heart Failure (AHF) (2 arms), sponsored by N/A. Primary endpoints: Renal function and Urinary [TIMP-2] x [IGFBP7]. Status: unknown.
02
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on TCTR20221003002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221003002.